Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report☆
Under an Elsevier user license
open archive
Keywords
rare diseases
clinical outcomes assessment
instrument development
clinical trials
Cited by (0)
- ☆
Co-chairs of this effort: Katy Benjamin and Margaret K. Vernon represent the ISPOR Rare Disease Clinical Outcomes Assessment Task Force (https://www.ispor.org/TaskForces/ClinicalOutcomesAssessment-RareDisease-ClinicalTrials.asp).
© 2017 Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research (ISPOR)